CXCL16 and neoplasm: Recent studies have highlighted the activation of the CXCL16/CXCR6 axis as a pivotal element in T cell-mediated tumor immunity,21 which is consistent with the increased proportion of CXCR6-high T cells we detected in interactions with M1-like TAMs.